Impulse control disorders and its association to medication use and other associated factors in patients with Parkinson's disease




parkinson's disease, risk factors, impulse control disorders


Objectives: Impulse control disorders (ICDs) are behaviors that are performed repeatedly, to the point of interfering with the patient's functionality and daily life, without regard for their consequences and with the sole purpose of obtaining immediate gratification. ICDs have been have been related to dopaminergic treatment. This study analyzes the association of different risk factors for the development of ICD in the Mexican population.

Methods: A cross-sectional study including 244 patients diagnosed with PD was carried out. The data collected were from the year 2021 to 2023. Data were collected through structured interviews including age, gender, year of symptom onset, year of diagnosis, levodopa equivalent dose, antiparkinsonian treatment, and history of smoking and alcohol use was evaluated.

Results: 244 patients with a diagnosis of Parkinson's disease were included, of whom 146 (59.8%) were men and 98 (40.2%) women with a mean age of 63+/-12.10 years. The sample population was divided into two groups, Group 1 were patients with ICD(ICD-PD) (n=35), and Group 2 Non-ICD (n=209). ICD was associated with alcohol use 2.390 (95% CI 0.02 - 1.72).A trend was found for the use of dopamine agonists (p=0.07) No statistically significant difference was found between groups regarding smoking habits, age at diagnosis, age at symptom onset, age, diagnostic delay, and levodopa equivalent doses.

Conclusions:  Use of alcohol and agonist dopaminergic were the main associated risk factor after multivariate logistic regression.


Martínez-Fernández R,Gasca-Salas C, Sánchez-Ferro A, Obeso JA. Actualización en la Enfermedad de Parkinson. Revista Médica Clínica Las Condes. Volume 27, May 2016, Pages 363-379. DOI: DOI:

Poewe W, Seppi K, Tanner CM, Halliday GM, Brundin P, Volkmann J, et al. Parkinson disease. Nat Rev Dis Primers. 2017 Mar 23;3:17013. Doi: 10.1038/nrdp.2017.13. DOI:

Enrique Chávez-León , Ontiveros-Uribe MP, Carrillo-Ruiz JD. La enfermedad de Parkinson: neurología para psiquiatras. Salud Mental 2013;36:315-324. DOI: 10.17711/SM.0185-3325.2013.038 DOI:

Daniel S, Marín M, Hans Carmona V, Melissa Ibarra Q, Manuela Gámez c. Parkinson disease: pathophysiology, diagnosis and treatment. Rev. Univ. Ind. Santander. Salud vol.50 no.1 Bucaramanga Jan./Mar. 2018. DOI: DOI:

Berganzo K, Tijero B, González-Eizaguirre A, Somme J, Lezcano E, Gabilondo I, Fernandez M, Zarranz JJ,Gómez-Esteban JC. Motor and non-motor symptoms of Parkinson's disease and their impact on quality of life and on different clinical subgroups.

Bhat S, Rajendra Acharya U , Hagiwara Y, Dadmehr N, Adeli H. Parkinson's disease: Cause factors, measurable indicators, and early diagnosis. Comput Biol Med. 2018 Nov 1;102:234-41. Doi: 10.1016/j.compbiomed.2018.09.008. DOI:

H. Evans A, Okai D, Weintraub D, Shen-Yang L, S. O’Sullivan S, Voon V, Krack P, Sampaio C, Leentjens A, Martinez-Martin P, T. Stebbins G, G. Goetz C, Schrag A, MD, and the Members of the International Parkinson and Movement Disorder Society (IPMDS) Rating Scales Review Committee. Scales to Assess Impulsive and Compulsive Behaviors in Parkinson’s Disease: Critique and Recommendations. Movement Disorders, Vol. 34, No. 6, 2019. DOI: 10.1002/mds.27689 DOI:

Pedro Vargas A, Costa Cardoso FE. Impulse control and related disorders in Parkinson’s disease. Arq. Neuro-Psiquiatr. 76 (6) • June 2018 • DOI: DOI:

Arango Uribe GJ, Bernal Pacheco O.Trastorno de control de impulsos (TCI) en enfermedad de Parkinson. Acta Neurol Colomb. vol.35. Sept. 2019. DOI: DOI:

López de la Hoz E. Trastorno de control de impulsos, una comorbilidad poco estudiada en la Enfermedad de Parkinson. 2023. URL:

Fernández-Prieto M, Lens M, López-Real A, Puy A, Dias-Silva JJ, Sobrido MJ. Alteraciones de la esfera emocional y el control de los impulsos en la enfermedad de Parkinson. REV NEUROL 2010;50 (Supl. 2):S41-S49. DOI: DOI:

Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, et al. MDS clinical diagnostic criteria for Parkinson's disease. Mov Disord. 2015;30:1591-601. Doi: 10.1002/mds.26424. DOI:

Cervantes-Arriaga A, Rodríguez-Violante M, Villar-Velarde A, Corona T. Cálculo de unidades de equivalencia de levodopa en enfermedad de Parkinson. Arch Neurocien (Mex) Vol. 14, No. 2: 116-119; 2009. URL:

Martinez-Martin P, Rodriguez-Blazquez C, Alvarez-Sanchez M, Arakaki T, Bergareche-Yarza A, Chade A, et al. Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS). J Neurol. 2013 Jan;260(1):228-36. DOI:

Weintraub D, Mamikonyan E, Papay K, A. Shea J, X. Xie S, Siderowf A. Questionnaire for Impulsive-Compulsive Disorders in Parkinson’s Disease–Rating Scale. Mov Disord. 2012 Feb; 27(2): 242–247. 2011.DOI: 10.1002/mds.24023 DOI:

Ávila A, Cardona X, Bello J, Maho P, Sastre F, Martín-Baranera M. Trastornos del control de los impulsos y punding en la enfermedad de Parkinson: la necesidad de una entrevista estructurada. Elsevier. Vol. 26.. Páginas 166-172 (Abril 2011). DOI: 10.1016/j.nrl.2010.09.007 DOI:

Parra-Medina LE, Góngora-Alfaro JL. Impulse control disorders: behavioral addictions in Parkinson 's disease. Revista eNeurobiología 11(27):061020, 2020. URL:www.uv.max/e neurobiologia/vols/2020/27/27.html DOI:

Cervantes-Arriaga A, Rodríguez-Violante M, Yescas P, , Alonso-Vilatela E. Fluctuaciones motoras en enfermedad de Parkinson. Revista Médica del Instituto Mexicano del Seguro Social [Internet]. 2012;50(2):141-146. Recuperado de:

Weintraub D, Mamikonyan E, M.S.Impulse Control Disorders in Parkinson 's Disease. Am J Psychiatry. 2019 Jan 1;176(1):5-11. doi: 10.1176/appi.ajp.2018.18040465. DOI:

Zhang JF, Wang XX, Feng Y, Fekete R, Jankovic J, Wu YC. Impulse Control Disorders in Parkinson's Disease: Epidemiology, Pathogenesis and Therapeutic Strategies. Front Psychiatry. 2021 Feb 9;12:635494. doi: 10.3389/fpsyt.2021.635494. DOI:

Joutsa J, Martikainen K, Vahlberg T, Kaasinen V. Effects of dopamine agonist dose and gender on the prognosis of impulse control disorders in Parkinson's disease. Parkinsonism Relat Disord. 2012 Dec;18(10):1079-83. doi: 10.1016/j.parkreldis.2012.06.005. DOI:

Weintraub D, Koester J, N. Potenza M, Impulse Control Disorders in Parkinson's Disease A Cross-Sectional Study of 3090 Patients. Arch Neurol. 2010;67(5):589-595. doi:10.1001/archneurol.2010.65 DOI:

Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, Rusjan P, Houle S, Strafella AP. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain. 2009 May;132(Pt 5):1376-85. doi: 10.1093/brain/awp054 DOI:

Weintraub D, D. Siderowf A, N. Potenza M, Goveas J, H. Morales K, Paul J , B. Stern M. Dopamine Agonist Use is Associated with Impulse Control Disorders in Parkinson’s Disease. Arch Neurol. 2006 Jul; 63(7): 969–973. doi: 10.1001/archneur.63.7.969 DOI:

Dongju S, M. Lacadie C, Sinha R. Neural Correlates and Connectivity Underlying Stress-Related Impulse Control Difficulties in Alcoholism. Alcoholism: clinical and experimental research. Volume 40, Issue9. September 2016. Pages 1884-1894. DOI: DOI:

Theis H, Probst C, Fernagut PO. Unlucky punches: the vulnerability-stress model for the development of impulse control disorders in Parkinson’s disease. npj Parkinsons Dis. 7, 112 (2021). DOI:

Rizo C, Villaseñor-Cabrera G, Jarne-Esparcia T, Zuñiga-Ramírez A, Soto-Escageda CA. (2018). Factores de riesgo para desarrollar Trastorno del control de los impulsos en Enfermedad de Parkinson. archivos de neurociencia, Vol. 10, No. 2, 2018. URL:

H. Erga A, Alves G, Bjørn Tysnes O, Freddy Pedersen K. Impulsive and compulsive behaviors in Parkinson's disease: Impact on quality of and satisfaction with life, and caregiver burden. Parkinsonism & Related Disorders. Volume 78, September 2020, Pages 27-30. DOI: DOI:

H. Baumann-Vogel H, Valko PO, Eisele G, Baumann CR. Impulse control disorders in Parkinson's disease: don't set your mind at rest by self-assessments. European Journal of Neurology. Volume22, Issue 4. April 2015. Pages 603-609. DOI: DOI:

Biundo R, Weis L, Abbruzzese G, et al. Impulse control disorders in advanced Parkinson’s disease with dyskinesia: the ALTHEA study. Mov Disord 2017;32:1557-1565. DOI: 10.1002/mds.27181 DOI:



How to Cite

Lira Juarez, L. G., Dominguez Garcia, A., Rodriguez Violante, M., Cervantes Arriaga, A., Santiago De La Cruz, E. C., Medrano Delgado, M. de los A. G., Hernandez Medrano, A. J., Regalado Mustafa, A. Y., & De La Rosa Patlan, G. E. (2023). Impulse control disorders and its association to medication use and other associated factors in patients with Parkinson’s disease. Archivos De Neurociencias, 1(Inpress).



Original Articles